278 related articles for article (PubMed ID: 26009563)
1. A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Gilbert GJ
Neurology; 2015 May; 84(21):2201. PubMed ID: 26009563
[No Abstract] [Full Text] [Related]
2. Biomarkers for MS: unpuzzling the progressive multiple sclerosis puzzle.
Fox RJ
Neurology; 2014 Oct; 83(17):1488-9. PubMed ID: 25253742
[No Abstract] [Full Text] [Related]
3. A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
Dickens AM; Larkin JR; Griffin JL; Cavey A; Matthews L; Turner MR; Wilcock GK; Davis BG; Claridge TD; Palace J; Anthony DC; Sibson NR
Neurology; 2014 Oct; 83(17):1492-9. PubMed ID: 25253748
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis.
DeMarshall C; Goldwaser EL; Sarkar A; Godsey GA; Acharya NK; Thayasivam U; Belinka BA; Nagele RG
J Neuroimmunol; 2017 Aug; 309():51-57. PubMed ID: 28601288
[TBL] [Abstract][Full Text] [Related]
5. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Malkki H
Nat Rev Neurol; 2014 Nov; 10(11):612. PubMed ID: 25287596
[No Abstract] [Full Text] [Related]
7. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
8. A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis.
Pasquali L; Lucchesi C; Pecori C; Metelli MR; Pellegrini S; Iudice A; Bonuccelli U
J Neuroimmunol; 2015 Jan; 278():53-9. PubMed ID: 25595252
[TBL] [Abstract][Full Text] [Related]
9. Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis.
Yun JW; Cvek U; Kilgore PCSR; Tsunoda I; Omura S; Sato F; Zivadinov R; Ramanathan M; Minagar A; Alexander JS
Life Sci; 2019 Jul; 229():116-123. PubMed ID: 31082401
[TBL] [Abstract][Full Text] [Related]
10. Sunshine and multiple sclerosis.
Taylor BV
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1066. PubMed ID: 23463872
[No Abstract] [Full Text] [Related]
11. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis.
Vukusic S; Confavreux C
J Neurol Sci; 2003 Feb; 206(2):135-7. PubMed ID: 12559500
[TBL] [Abstract][Full Text] [Related]
12. Natural history of multiple sclerosis.
Ebers GC
J Neurol Neurosurg Psychiatry; 2001 Dec; 71 Suppl 2(Suppl 2):ii16-9. PubMed ID: 11701779
[No Abstract] [Full Text] [Related]
13. Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Oliveira SR; Kallaur AP; Reiche EMV; Kaimen-Maciel DR; Panis C; Lozovoy MAB; Morimoto HK; Maes M; Dichi I; Simão ANC
Mol Neurobiol; 2017 May; 54(4):2961-2968. PubMed ID: 27026183
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis: predicting risk and delaying progression.
Yeh EA; Weinstock-Guttman B
Lancet Neurol; 2010 Jan; 9(1):7-9. PubMed ID: 20083024
[No Abstract] [Full Text] [Related]
15. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Muris AH; Rolf L; Broen K; Hupperts R; Damoiseaux J; Smolders J
J Steroid Biochem Mol Biol; 2016 Nov; 164():254-257. PubMed ID: 26598277
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in the CSF: macro-advance in MS?
Meinl E; Meister G
Neurology; 2012 Nov; 79(22):2162-3. PubMed ID: 23077022
[No Abstract] [Full Text] [Related]
17. [Diagnostic and prognostic potential of MRI in multiple sclerosis].
Pronin IN; Beliaeva IA; Boĭko AN; Kornienko VN; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; (Spec No 2):18-24. PubMed ID: 12938630
[No Abstract] [Full Text] [Related]
18. Raised endothelial microparticles an early marker for multiple sclerosis?
Larkin M
Lancet; 2001 May; 357(9269):1679. PubMed ID: 11425383
[No Abstract] [Full Text] [Related]
19. Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis.
Maier S; Barcutean L; Andone S; Manu D; Sarmasan E; Bajko Z; Balasa R
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901807
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis.
Katz Sand I; Krieger S; Farrell C; Miller AE
Mult Scler; 2014 Oct; 20(12):1654-7. PubMed ID: 24493475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
